Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Selective 5-HT1D receptor agonists from MS&D useful for migraine

Dec. 18, 1998

Chirocaine receives first regulatory approval in Sweden

Dec. 18, 1998

Lilly patents novel mGluR modulators

Dec. 18, 1998

Patent claims relating to use of Avant's TP-20 in stroke allowed

Dec. 17, 1998

Another market launch for Orion's COMT inhibitor

Dec. 17, 1998

Zeneca's new pain-relieving agents revealed in patent literature

Dec. 17, 1998

Studies using 5-ht6 antagonist Ro-04-6790 provide new clues about receptor function

Dec. 17, 1998

NPS Pharmaceuticals updates epilepsy program

Dec. 17, 1998

Novel glutamate receptor antagonist shows excellent potential as antiepileptic agent

Dec. 15, 1998

Merckle launches new treatment for narcolepsy in Germany

Dec. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...